May 29, 2017 | Hong Kong-based investment group AID Partners has acquired Israeli diagnostics startup GeneSort for $23 million. Founded in 2013, GeneSort is led by Dr. Gil Pogozelich. The molecular diagnostics company is focused on integrating genomics with personalized therapeutic approaches.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments